Final Report on the Safety Assessment of Malic Acid and Sodium Malate

Abstract

Malic Acid functions in cosmetic formulations as a pH adjuster, and Sodium Malate functions as a skin conditioning agent-humectant. Malic Acid is reportedly used in almost 50 cosmetic formulations across a range of product types at low concentrations, whereas Sodium Malate is used in only one. As a pH adjuster, Malic Acid is used at low concentrations. One commercial method of preparing Malic Acid is hydration of fumaric acid or maleic acid, and then purified to limit the amount of the starting material present. Because Malic Acid is a component of the Kreb's cycle, another method is fermentation. Malic Acid was relatively nontoxic in acute toxicity studies using animals. In a chronic oral study, feeding Malic Acid to rats resulted only in weight gain changes and changes in feed consumption. Malic Acid did not cause reproductive toxicity in mice, rats, or rabbits. Malic Acid was a moderate to strong skin irritatant in animal tests, and was a strong ocular irritant. Malic Acid was not mutagenic across a range of genotoxicity tests. Malic Acid was irritating in clinical tests, with less irritation seen as pH of the applied material increased. Patients patch tested with Malic Acid, placed on a diet that avoided foods containing Malic or citric acid, and then challenged with a diet high in Malic and citric acid had both immediate urticarial and delayed contact dermatitis reactions. These data were considered sufficient to determine that Malic Acid and Sodium Malate would be safe at the low concentrations at which these ingredients would be used to adjust pH (even though Sodium Malate is not currently used for that purpose). The data, however, were insufficient to determine the safety of these ingredients when used in cosmetics as other than pH adjusters and specifically, the data are insufficient to determine the safety of Sodium Malate when used as a skin conditioning agent-humectant. The types of data required for the Expert Panel to determine the safety of Sodium Malate as a skin-conditioning agent are: concentration of use data; dermal irritation and sensitization data; and ocular irritation data, if available. The data needed to assess the safety of Malic Acid or Sodium Malate for some function other than as a skin-conditioning agent cannot be specified without knowing the intended function. Were these ingredients to be used as exfoliants, for example, data similar to that included in the Cosmetic Ingredient Review safety assessment of Glycolic Acid would be needed. Until these data are available, it is concluded that the available data are insufficient to support the safety of these ingredients in cosmetic formulations for functions other than use as a pH adjuster.

References

Agarwal, V. K.

1988. Simultaneous determination of D-and L-Malic Acids in apple juice by gas chromatography. J. Assoc. Off. Anal. Chem.71:466–468.

Al-Ani, F. Y.

, and

S. K. Al-Lami

. 1988. Absence of mutagenic activity of acidity regulators in the Ames Salmonella/microsome test. Mutat. Res.206:467–470.

Andersen, F. A.

, ed. 1998. Final report on the safety of Glycolic Acid, Ammonium, Calcium, Potassium, and Sodium Glycolates, Methyl, Ethyl, Propyl, and Butyl Glycolates, and Lactic Acid, Ammonium, Calcium, Potassium, Sodium, and TEA-Lactates, Methyl, Ethyl, Isopropyl, and Butyl Lactate, and Lauryl, Myristyl, and Cetyl Lactates. Int. J. Toxicol.17:1–241.

Brookdale Dental Center of New York University

. 1973. Letter from Dr. JR Stern to Dr. B La Du summarizing the results of testing acute testing with forms of Malic Acid. (Submitted by FDA in response to an FOI request; 1 page.)2

Budavari, S.

, ed. 1989. The Merck index. An encyclopedia of chemicals, drugs, and biologicals. 11th ed., 896. Rahwah, NJ: Merck & Co.

Chang, T-L

R. P. Streicher

H. Zimmer

, and

J. W. Munch

. 1988. The interaction of aqueous solutions of chlorine with Malic Acid, tartaric acid, and various fruit juices. A source of mutagens. Anal. Lett.21:2049–2067.

Daniel, J. W.

1969. The metabolism of L-and DL-Malic Acid by rats. Food Cosmet. Toxicol.7:103–106.

Eisele, T. A.

1996. Determination of D-Malic Acid in apple juice by liquid chromatography: Collaborative study. J. A. O. A. C. Intl.79:50–54.

European Economic Community (EEC)

. 1995. EEC Cosmetics Directive 76/768/EEC, as amended, Annexes I through VII. Brussels: EEC.

10.

Food

and

Agriculture Organization of the United Nations/World Health Organization (FAO/WHO)

. 1967. Toxicological evaluation of some antimicrobials, antioxidants, emulsifiers, stabilizers, flour-treatment agents, acids, and bases. (Submitted by FDA in response to an FOI request; 3 pages.)2

11.

FAO/WHO

. 1969. 13th Report—Specifications for the identity and purity of food additives, and their toxicological evaluation, etc. May 27-June 4. (Submitted by FDA in response to an FOI request; 3 pages.)2

12.

FAO/WHO

. 1994. Summary of evaluations performed by the Joint FAO/WHO Expert Committee on Food Additives (JECFA), M-6. USA: International Life Sciences Institute.

13.

Food

and

Drug Administration (FDA)

. 1984. Cosmetic product formulation and frequency of use data. FDA database. Washington, DC: FDA.

14.

FDA

. 1992. Modification in voluntary filing of cosmetic product ingredient and cosmetic raw composition statements. Fed. Register57:3128–3130.

15.

FDA

. 1997. Direct food substances generally recognized as safe and requirements for specific standardized milk and cream. Code of Federal Regulations, Title 21. $131.111; $169.115; $169.140; $169.150; $184.1069.

16.

FDA

. 1998. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.

17.

Food

and

Drug Research Labs, Inc. (FDRL)

. 1973a. Scientific literature reviews on generally recognized as safe (GRAS) food ingredients—Malic Acid. Prepared for the FDA. June. NTIS Report No. PB-223 865.

18.

FDRL

. 1973b. Oral LD50 for mice of FDA 71-90 (Pomalus Malic Acid). Laboratory No. 1762r; contract No. FDA 71-260. Study dated Oct 16. (Submitted by FDA in response to an FOI request; 2 pages.)2

19.

FDRL

. 1973c. Oral LD50 for rats of FDA 71-90 (Pomalus Malic Acid). Laboratory No. 1763r; Contract No. FDA 71-260. Study dated Oct 16. (Submitted by FDA in response to an FOI request; 2 pages.)2

20.

FDRL

. 1973d. Oral LD50 for rabbits of FDA 71-90 (Pomalus Malic Acid). Laboratory No. 1764r; Contract No. FDA 71-260. Study dated Nov 29. (Submitted by FDA in response to an FOI request; 2 pages.)2

21.

FDRL

. 1974a. Teratologic evaluation of FDA 71-90 (Pomalus Malic Acid) in mice. Laboratory No. 1765r; Contract No. FDA 71-260. Study dated Jan 14. (Submitted by FDA in response to an FOI request; 10 pages.)2

22.

FDRL

. 1974b. Teratologic evaluation of FDA 71-90 (Pomalus Malic Acid) in rats. Laboratory No. 1766r; Contract No. FDA 71-260. Study dated Jan 14. (Submitted by FDA in response to an FOI request; 17 pages.)2

23.

FDRL

. 1974c. Teratologic evaluation of FDA 71-90 (Pomalus Malic Acid) in rabbits. Laboratory No. 1767r; Contract No. FDA 71-260. Study dated May 17. (Submitted by FDA in response to an FOI request; 14 pages.)2

24.

Furia, T. E.

, ed. 1972. Handbook of food additives, 2nd ed., 239-241. Cleveland: CRC Press.

25.

Furia, T. E.

, ed. 1975. Fenaroli's handbook of flavor ingredients, 2nd ed., 326. Boca Raton, FL: CRC Press.

26.

Grant, J.

, ed. 1972. Hackh's chemical dictionary, 4th ed., 404. New York: McGraw-Hill.

27.

Hazleton Laboratories, Inc

. 1970. Final report: Two-generation reproduction study using rats of X-5120. Project No. 165-128. Study dated Nov 11. (Submitted by FDA in response to an FOI request; 25 pages.)2

28.

Ishidate, M. Jr.

T. Sofuni

K. Yoshikawa

, et al. 1984. Primary mutagenicity screening of food additives currently used in Japan. Food Chem. Toxicol.22:623–636.

29.

Kuroda, M.

D. Yoshida

, and

S. Mizusaki

. 1985. Mutagenicity of pyrolyzates of natural substances toward Salmonella typhimurium TA97. Agric. Biol. Chem.49:1893–1895.

30.

Lewis, R. J., Sr.

1993a. Hawley's condensed chemical dictionary, 12th ed., 725. New York: Van Nostrand Reinhold.

31.

Lewis, R. J., Sr.

1993b. Hazardous chemicals desk reference, 3rd ed., 791. New York: Van Nostrand Reinhold Company.

32.

Liebrand, J. T.

1992. Encyclopedia of food science and technology, vol 1, 1–6. New York: Wiley and Sons.

33.

Litton Bionetics, Inc

. 1974. Mutagenic evaluation of compound FDA 71-90. Report dated Nov 25 submitted to the FDA. NTIS Report No. PB-245440.

34.

Martin, G. J.

, and

W. Stenzel

. 1944. The influence of various chemicals and vitamin deficiencies on the excretion of glucuronic acid in the rat. Arch. Biochem.3:325–331.

35.

Miltenberger, K

. 1989. Ullmann's encyclopedia of industry chemistry, 5th ed., vol. A13, 515–517. New York: VCH Publishing.

36.

National Academy of Sciences (NAS)

. 1996. Food Chemicals Codex, 4th ed., 237–238. Washington, DC: National Academy Press.

37.

Nikitakis, J. M.

, and

G. N. McEwen, Jr.

, eds. 1990. CTFA Compendium of cosmetic ingredient composition—descriptions I. Washington, DC: CTFA.

38.

Patty

. (1981-2). Patty's industrial hygiene and toxicology, 3rd ed., 4937, 4941–4942. New York: Wiley and Sons.

39.

Registry of Toxic Effects of Chemical Substances (RTECS)

. 1997. Malic Acid entry. RTECS database. Bethesda, MD: National Library of Medicine.

40.

Rempe, J. M.

, and

L. G. Santucci

. 1997. CTFA list of Japanese cosmetic ingredients, 3rd ed., 62. Washington, DC: CTFA.

41.

Russell, I. J.

J. E. Michalek

J. D. Flechas

, and

G. E. Abraham

. 1995. Treatment of fibromyalgia syndrome with Super Malic. A randomized, double blind, placebo controlled, crossover pilot study. J. Rheumatol.22:953–958.

42.

Sax, N. I.

1979. Dangerous properties of industrial materials, 5th ed., 785. New York: Van Nostrand Reinhold Company.

43.

Smith, W. P.

1996. Comparative effectiveness of α-hydroxy acids on skin properties. Intl. J. Cosmet. Sci.18:75–83.

44.

Suye, S.-I.

N. Yoshihara

, and

S. Inuta

. 1992. Spectrophotometric determination of L-Malic Acid with a malic enzyme. Biosci. Biotech. Biochem.56:1488–1489.

45.

Taylor, E. J.

, ed. 1988. Dorland's illustrated medical dictionary, 27th ed., 975. Philadelphia, PA: WB Saunders.

46.

TRW/Hazleton Laboratories

. 1971a. Final report: 24-month dietary administration to rats of compound X-5120. Project No. 165-126. Study dated Oct 19. (Submitted by FDA in response to an FOI request; 215 pages.)2

47.

TRW/Hazleton Laboratories

. 1971b. Final report: 104-week dietary administration to dogs of X-5120. Project No. 165-129. Study dated Oct 15. (Submitted by FDA in response to an FOI request; 150 pages.)2

48.

US Pharmacopeial Convention, Inc

. 1995. The United States pharmacopeia, vol 23, and The national formulary, vol 18, 2262–2263. Taunton, MA: Rand McNally.

49.

Van Scott

E. J.

, and

R. J. Yu

. 1974. Control of keratinization with α-hydroxy acids and related compounds. I. Topical treatment of ichthyotic disorders. Arch. Dermatol.110:586–590.

50.

Walsh, W. E.

1979. Atopic dermatitis associated with citric and Malic Acid intolerance. Minn. Med.62:637–639.

51.

Wenninger, J. A.

R. C., Canterbery

, and

G. N. McEwen, Jr.

, eds. 2000. International cosmetic ingredient dictionary and handbook, 8th ed., vol 1-2. Washington, DC: CTFA.

52.

Yamamoto, A.

A. Matsunaga

, and

E. Mizukami

. 1991. Ligand-exchange ion chromatographic determination of Malic Acid enantiomers in apple juice with photometric detection. J. Chromatogr.585:315–317.

53.

Yoshida, D.

, and

H. Okamoto

. 1982. Mutagenicity of the pyrolysis products of ammonium salts. Agric. Biol. Chem.46:1087–1088.